BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28112515)

  • 41. Synthesis, biological, and photophysical studies of molecular rotor-based fluorescent inhibitors of the trypanosome alternative oxidase.
    Cueto-Díaz EJ; Ebiloma GU; Alfayez IA; Ungogo MA; Lemgruber L; González-García MC; Giron MD; Salto R; Fueyo-González FJ; Shiba T; González-Vera JA; Ruedas Rama MJ; Orte A; de Koning HP; Dardonville C
    Eur J Med Chem; 2021 Aug; 220():113470. PubMed ID: 33940464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes.
    Kuboki N; Yokoyama N; Kojima N; Sakurai T; Inoue N; Sugimoto C
    J Parasitol; 2006 Apr; 92(2):389-93. PubMed ID: 16729700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indirubin Analogues Inhibit
    Efstathiou A; Gaboriaud-Kolar N; Myrianthopoulos V; Vougogiannopoulou K; Subota I; Aicher S; Mikros E; Bastin P; Skaltsounis AL; Soteriadou K; Smirlis D
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mitochondrion in bloodstream forms of Trypanosoma brucei is energized by the electrogenic pumping of protons catalysed by the F1F0-ATPase.
    Nolan DP; Voorheis HP
    Eur J Biochem; 1992 Oct; 209(1):207-16. PubMed ID: 1327770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.
    Urbaniak MD; Mathieson T; Bantscheff M; Eberhard D; Grimaldi R; Miranda-Saavedra D; Wyatt P; Ferguson MA; Frearson J; Drewes G
    ACS Chem Biol; 2012 Nov; 7(11):1858-65. PubMed ID: 22908928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanosoma brucei and T. vivax: salicylhydroxamic acid and glycerol treatment of acute and chronically infected rats.
    van der Meer C; Versluijs-Broers JA
    Exp Parasitol; 1986 Aug; 62(1):98-113. PubMed ID: 3720904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of
    Balogun EO; Inaoka DK; Shiba T; Tsuge C; May B; Sato T; Kido Y; Nara T; Aoki T; Honma T; Tanaka A; Inoue M; Matsuoka S; Michels PAM; Watanabe YI; Moore AL; Harada S; Kita K
    FASEB J; 2019 Nov; 33(11):13002-13013. PubMed ID: 31525300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
    West RA; O'Doherty OG; Askwith T; Atack J; Beswick P; Laverick J; Paradowski M; Pennicott LE; Rao SPS; Williams G; Ward SE
    Eur J Med Chem; 2017 Dec; 141():676-689. PubMed ID: 29107420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.
    Rahmani R; Ban K; Jones AJ; Ferrins L; Ganame D; Sykes ML; Avery VM; White KL; Ryan E; Kaiser M; Charman SA; Baell JB
    J Med Chem; 2015 Sep; 58(17):6753-65. PubMed ID: 26247439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-
    Fytas G; Zoidis G; Taylor MC; Kelly JM; Tsatsaroni A; Tsotinis A
    Future Med Chem; 2019 Jun; 11(11):1259-1266. PubMed ID: 31161793
    [No Abstract]   [Full Text] [Related]  

  • 54. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
    Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
    Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trypanosoma brucei: an evaluation of salicylhydroxamic acid as a trypanocidal drug.
    Opperdoes FR; Aarsen PN; van der Meer C; Borst P
    Exp Parasitol; 1976 Oct; 40(2):198-205. PubMed ID: 971725
    [No Abstract]   [Full Text] [Related]  

  • 58. Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis.
    Thomas SM; Purmal A; Pollastri M; Mensa-Wilmot K
    Sci Rep; 2016 Aug; 6():32083. PubMed ID: 27561392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trypanocidal activity of tetradentated pyridine-based manganese complexes is not linked to inactivation of superoxide dismutase.
    Steverding D; Kolosevska K; Sánchez-Moreno M
    Exp Parasitol; 2018 Sep; 192():1-5. PubMed ID: 30026114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative pathogenicity of drug-resistant and drug-sensitive Trypanosoma brucei and Trypanosoma congolense infections in Nigerian local dogs.
    Obi CF; Okpala MI; Anyogu DC; Onyeabor A; Ezeh IO; Ezeokonkwo RC
    Parasitol Res; 2023 Jan; 122(1):49-60. PubMed ID: 36251088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.